log in
Print | Back

MinterEllison

Daniel Scotti

Daniel Scotti

Partner

MinterEllison
Australia

tel: +61 2 9921 4360
Send an Email

Local Time: Sat. 17:49

Profile

Daniel specialises in capital markets and mergers and acquisitions. He has extensive experience in all forms of equity and hybrid capital raisings and other corporate finance transactions, as well as public and private merger and acquisition deals.

Daniel has advised on many IPOs (including dual track process and dual listings), placements, rights issues and entitlement offers, other secondary offers, secondary sales and convertible and corporate bond offers. His clients include the full spectrum of company and managed investment scheme issuers, private equity sponsors, institutional investors and lead managers and underwriters. Daniel's merger and acquisition experience covers private treaty trade sales, sales and acquisitions by private equity sponsors, as well as public transactions, such as schemes of arrangement and regulated takeover bids. He also advises clients on the Corporations Act and ASX Listing Rule compliance, reporting and disclosure obligations.

Daniel also has extensive international corporate finance experience, having worked on cross border transactions in Australia and for a top-tier law firm in New York, working on equity financing, both investment grade and high-yield debt financings, debt tender offers and spin-offs.

Areas of Practice
Articles

Australian Life Sciences and Biotech - Key Themes and Trends
MinterEllison, October 2018

The Australian life sciences and biotech sector is likely to continue its resurgence over the next twelve months, with global trends driving strong M&A activity in life sciences and biotech M&A. We have identified 6 key themes for activity in this sector. Three Key Opportunities  1. Demographic Trend According to the Australian Institute of Health and Welfare, healthcare expenditure in Australia is growing faster than population growth and GDP growth...

Australian Life Sciences and Biotech - Key Themes and Trends
MinterEllison, July 2018

The Australian life sciences and biotech sector is likely to continue its resurgence over the next twelve months, with global trends driving strong M&A activity in life sciences and biotech M&A. We have identified 6 key themes for activity in this sector. Three Key Opportunities Demographic Trend According to the Australian Institute of Health and Welfare, healthcare expenditure in Australia is growing faster than population growth and GDP growth...

Additional Articles

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2019